Changing Paradigms-An Update on the Multidisciplinary Management of Malignant Glioma

Changing Paradigms-An Update on the Multidisciplinary Management of Malignant Glioma Roger Stupp, Monika E. Hegi, Martin J. van den Bent, Warren P. Mason, Michael Weller, René O. Mirimanoff, J. Gregory Cairncross Oncologist 2006; 11: 165-180 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in the field of Neuro-Oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: List the different major subtypes of glioma and identify the appropriate treatment strategies for patients with high-grade and low-grade gliomas. Discuss the available evidence for the treatment of newly diagnosed glioblastoma, anaplastic astrocytoma, and anaplastic oligodendroglioma. Identify approved agents and other active or investigational agents used to treat patients with newly diagnosed and recurrent glioma. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 13, 2006 Most Recent Review: May 8, 2007* Most Recent Update: Feb. 13, 2006 Date Credit Expires: Feb. 13, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.